The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Effect of Statins on Skeletal Muscle Function
Open accessAbstract
Background—: Many clinicians believe that statins cause muscle pain, but this has not been observed in clinical trials, and the effect of statins on muscle performance has not been carefully studied. Methods and Results—: The Effect of Statins on Skeletal Muscle Function and Performance (STOMP) study assessed symptoms and measured creatine kinase, exercise capacity, and muscle strength before and after atorvastatin 80 mg or placebo was administered for 6 months to 420 healthy, statin-naive subjects. No individual creatine kinase value exceeded 10 times normal, but average creatine kinase increased 20.8±141.1 U/L ( P <0.0001) with atorvastatin. There were no significant changes in several measures of muscle strength or exercise capacity with atorvastatin, but more atorvastatin than placebo subjects developed myalgia (19 versus 10; P =0.05). Myalgic subjects on atorvastatin or placebo had decreased muscle strength in 5 of 14 and 4 of 14 variables, respectively ( P =0.69). Conclusions—: These results indicate that high-dose atorvastatin for 6 months does not decrease average muscle strength or exercise performance in healthy, previously untreated subjects. Nevertheless, this blinded, controlled trial confirms the undocumented impression that statins increase muscle complaints. Atorvastatin also increased average creatine kinase, suggesting that statins produce mild muscle injury even among asymptomatic subjects. This increase in creatine kinase should prompt studies examining the effects of more prolonged, high-dose statin treatment on muscular performance. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00609063.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the 420 statin-naïve subjects randomized to atorvastatin 80 mg daily or placebo for 6 months, 9.4% of the statin-treated and 4.6% of control subjects met the study definition of myalgia (P = 0.054)”
In the citing paper
“The STOMP study also found no differences in the measures of muscle strength or exercise performance between statin-treated and placebo subjects.”
In the citing paper
“The Effects of Statins on Muscle Performance (STOMP) study is, to our knowledge, the only randomized, double-blind, placebo-controlled study specifically designed to examine the effect of statins on skeletal muscle symptoms and performance.22”
In the citing paper
“suggesting that the incidence of muscle complaints due to the statin is considerably less than that reported in observational trials.”
In the citing paper
“Discomfort and weakness typically occur early (within 4–6 weeks after starting statin therapy22), but may still occur after many years of treatment.”
In the citing paper
“One study, designed specifically to study the effects of statins on muscle symptoms, suggests that the frequency of muscle-related complaints is ≏ 5%. 217”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [217]
In the citing paper
“Medications such as statins may provoke symptoms such as muscle pain or weakness, which can be confused with normal post-exercise soreness, especially in individuals not accustomed to PRT [[588], [589], [590]].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [588]
In the citing paper
“Medications such as statins may provoke symptoms such as muscle pain or weakness, which can be confused with normal post-exercise soreness, especially in individuals not accustomed to PRT [[588], [589], [590]].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [588]
In the citing paper
“One study, designed specifically to study the effects of statins on muscle symptoms, suggests that the frequency of muscle-related complaints is ~5%.217”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [217]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Arky, R. A. (1994) · Cited by 2,632
Thompson, P. D., Clarkson, P., & Karas, R. H. (2003) · JAMA · doi:10.1001/jama.289.13.1681 · Cited by 1,463
Self-citationBruckert, E., Hayem, G., Dejager, S., Yau, C., & Bégaud, B. (2005) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-005-5686-z · Cited by 1,226
ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins
Writing Committee Members:, Pasternak, R. C., Smith, S. C., Bairey-Merz, C. N., Grundy, S. M., Cleeman, J. I., & Lenfant, C. (2002) · Circulation · doi:10.1161/01.cir.0000032466.44170.44 · Cited by 1,088
Cerivastatin and Reports of Fatal Rhabdomyolysis
Staffa, J. A., Chang, J. T., & Green, L. (2002) · New England Journal of Medicine · doi:10.1056/nejm200202143460721 · Cited by 627
Statin-associated myopathy with normal creatine kinase levels
Phillips, P. S., Haas, R. H., Bannykh, S., Hathaway, S., Gray, N. L., Kimura, B. J., Vladutiu, G. D., England, J. D. F., & and the Scripps Mercy Clinical Research Center* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00009 · Cited by 565
Pasternak, R. C., Smith, S. C., Merz, C. N. B., Grundy, S. M., Cleeman, J. I., & Lenfant, C. J. M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02030-2 · Cited by 497
The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity
Hanai, J., Cao, P., Tanksale, P., Imamura, S., Koshimizu, E., Zhao, J., Kishi, S., Yamashita, M., Phillips, P. S., Sukhatme, V. P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32741 · Cited by 281
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 501
McFadden, E. C., Stevens, R., Glasziou, P., & Perera, R. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.11.004 · Cited by 6
Rhabdomyolysis Occurring under Statins after Intense Physical Activity in a Marathon Runner
Toussirot, É., Michel, F., & Meneveau, N. (2015) · Case Reports in Rheumatology · doi:10.1155/2015/721078 · Cited by 6
Current Controversies With Recent Cholesterol Treatment Guidelines
Phillips, E., & Saseen, J. J. (2015) · Journal of Pharmacy Practice · doi:10.1177/0897190015615880 · Cited by 6
Trial designs for statin muscle intolerance
Rosenson, R. S. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000454 · Cited by 6
Seo, D. Y., Heo, J., No, M., Yoo, S.-Z., Ko, J. R., Park, D., Kang, J., Kim, C., Jung, S., Han, J., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072292 · Cited by 6
Predictors of a successful statin reattempt after an adverse reaction
Zhang, H., Plutzky, J., Ge, W., Shubina, M., & Turchin, A. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.02.005 · Cited by 6
Yang, N. V., Rogers, S. W., Guerra, R. M., Pagliarini, D. J., Theusch, E., & Krauss, R. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.24.546411 · Cited by 6
Statin-Intolerant Patients Exhibit Diminished Muscle Strength Regardless of Lipid-Lowering Therapy
Vinci, P., Girolamo, F. G. D., Pellicori, F., Panizon, E., Pirulli, A., Tosoni, L. M., Altamura, N., Rizzo, S., Perin, A., Fiotti, N., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041221 · Cited by 5
Diagnosis and Management of Statin-Associated Muscle Symptoms
Cha, J., & Hong, S. J. (2025) · Korean Circulation Journal · doi:10.4070/kcj.2025.0285 · Cited by 5
Barinda, A. J., Hardi, H., Louisa, M., Khatimah, N. G., Marliau, R. M., Felix, I., Fadhillah, M. R., & Jamal, A. K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1373458 · Cited by 6
A Meta‐Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases
Li, W., Wang, D., Lin, C., Cai, T., Zhao, M., Liang, L., Zhao, X., He, X., Liang, X., & Zheng, J. (2025) · Cardiovascular Therapeutics · doi:10.1155/cdr/6684099 · Cited by 8
Effect of SLCO1B1 T521C on Statin-induced Myotoxicity: A Systematic Review and Meta-analysis
Lee, Y. S., & Chun, P. (2018) · Korean Journal of Clinical Pharmacy · doi:10.24304/kjcp.2018.28.4.320 · Cited by 5
Казаков, Р. Е., Чеча, О. А., Мазеркина, И. А., Demchenkova, E. Y., Александрова, Т. А., Евтеев, В. А., Белков, С. А., & Prokofiev, A. B. (2020) · Safety and Risk of Pharmacotherapy · doi:10.30895/2312-7821-2020-8-1-43-51 · Cited by 5
Neurological complications of cardiovascular drugs
Kelly, M. A. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819814-8.00020-2 · Cited by 5
Diagnostik und Therapie von statinassoziierten Muskelsymptomen
Kassner, U., Grunwald, S. A., Spira, D., Buchmann, N., Bobbert, T., Gazzerro, E., Hollstein, T., Spuler, S., & Steinhagen‐Thiessen, E. (2021) · Der Internist · doi:10.1007/s00108-021-01059-0 · Cited by 5
Statinintoleranz und statinassoziierte Muskelschmerzen
Stürzebecher, P. E., Schumann, F., Kassner, U., & Laufs, U. (2022) · Herz · doi:10.1007/s00059-022-05114-w · Cited by 5
Ju, Z., Guan, X., Zhang, B., Wang, J., Jin, X., Zhao, Y., & Li, B. (2023) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-023-00606-4 · Cited by 4
Effects of Atorvastatin on Resting and Peak Exercise Blood Pressure among Normotensive Men and Women
Zaleski, A. L., Mentch, M. L., Pescatello, L. S., Taylor, B. A., Capizzi, J. A., Grimaldi, A. S., Clarkson, P. M., Moeckel‐Cole, S., Chipkin, S. R., Keadle, J., et al. (2014) · Cholesterol · doi:10.1155/2014/720507 · Cited by 5
Self-citationAmmendola, S., Stoppoloni, D., Loreto, M. D., & d’Abusco, A. S. (2016) · Journal of the American College of Nutrition · doi:10.1080/07315724.2015.1093972 · Cited by 5
Statin associated myopathy in clinical practice. Results of DAMA study
Millán, J., Pedro‐Botet, J., Climent, E., Millán, J., & Rius, J. (2017) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2016.07.001 · Cited by 5
Influence of Baseline Psychological Health on Muscle Pain During Atorvastatin Treatment
Zaleski, A. L., Taylor, B. A., Pescatello, L. S., Dornelas, E. A., White, C. M., & Thompson, P. D. (2016) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000382 · Cited by 5
Self-citationManagement Strategies for Statin-Associated Muscle Symptoms: How Useful Is Same-Statin Rechallenge?
Brennan, E. T., & Joy, T. R. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.02.013 · Cited by 5
Synergistic interaction between B vitamins and statins to counter nociception in rats
López‐Canales, J. S., Estefania, R. P., Carolina, G. M. P., Mery, L. R., Castillo-Henkel, E. F., & Lozano‐Cuenca, J. (2020) · Drug Development Research · doi:10.1002/ddr.21767 · Cited by 5
Dietary Habits and Musculoskeletal Pain in Statin and Red Yeast Rice Users: A Pilot Study
Raguzzini, A., Toti, E., Palmery, M., Abdel‐Daim, M. M., & Peluso, I. (2021) · European Journal of Investigation in Health Psychology and Education · doi:10.3390/ejihpe11040085 · Cited by 5
Physical Activity and Exercise for Older Adults
Mora, J. C., & Valencia, W. M. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108942751.007 · Cited by 5
Statin-associated muscle symptoms: Myth or reality?
Blanco, A. M., Gómez-Huelgas, R., & Gómez-Cerezo, J. F. (2022) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2022.03.006 · Cited by 5
Carallo, C., Capozza, A., & Gnasso, A. (2022) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0127 · Cited by 5
Ballard, K. D., Mazur, S. M., Taylor, B. A., & Thompson, P. D. (2015) · The Physician and Sportsmedicine · doi:10.1080/00913847.2016.1135038 · Cited by 5
Self-citationSimard, C., Paquin, A., & Schwartz, B. C. (2020) · American Journal of Case Reports · doi:10.12659/ajcr.922568 · Cited by 5
Statin-associated muscle injury
Ballard, K. D., Taylor, B. A., & Thompson, P. D. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315586096 · Cited by 5
Self-citationIntermuscular Adipose Tissue in CKD
Demirci, M., Dilaver, R. G., Roshanravan, B., Ikizler, T. A., & Gamboa, J. L. (2025) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000745 · Cited by 4
Myalgies et statines : démêler le vrai du faux
Blacher, J., Bruckert, É., Farnier, M., Ferrières, J., Henry, P., Krempf, M., & Mourad, J. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.07.034 · Cited by 4
Challenges in Treating Statin-Associated Necrotizing Myopathy
Webster, P., Wiemer, N., Harash, A. A., Marshall, C., Khatoon, N., & Lucke, M. (2021) · Case Reports in Rheumatology · doi:10.1155/2021/8810754 · Cited by 4
False versus True Statin Intolerance in Patients with Peripheral Artery Disease
Dopheide, J. F., Gillmann, P., Spirk, D., Borozadi, M. K., Adam, L., & Drexel, H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226619 · Cited by 3
Advances in the development and use of human tissue-based techniques for drug toxicity testing
Clotworthy, M., & Archibald, K. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.802770 · Cited by 4
Liu, D., Shen, T., Ren, C., Xu, S., Zhou, L., Bai, J., Li, N., Zhao, W., & Gao, W. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1786533 · Cited by 4
Sedykh, D. Y., Hryachkova, O. N., Кашталап, В. В., & Барбараш, О. Л. (2021) · Russian Medical Inquiry · doi:10.32364/2587-6821-2021-5-4-218-224 · Cited by 4
A microRNA Signature for the Diagnosis of Statins Intolerance
Mangas, A., Pérez-Serra, A., Bonet, F., Muñiz-Grijalvo, O., Fuentes, F. J., González-Estrada, A., Campuzano, Ó., Roca, J. S. R., Alonso-Villa, E., & Toro, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158146 · Cited by 4
Lim, Y. Z., Cicuttini, F., Wluka, A. E., Jones, G., Hill, C. L., Forbes, A. B., Tonkin, A. M., Berezovskaya, S., Tan, L., Ding, C., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.939800 · Cited by 4
Sarzani, R., Allevi, M., Giulietti, F., Sarnari, S., Scorcella, S., Agostini, A. D., Turri, P., Pentima, C. D., & Spannella, F. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.08.011 · Cited by 5
L’intolérance musculaire aux statines
Boulanger‐Piette, A., Bergeron, J., Desgreniers, J., Côté-Levesque, M., Brassard, D., Joanisse, D. R., & Frenette, J. (2015) · médecine/sciences · doi:10.1051/medsci/20153112014 · Cited by 4
ESC-Leitlinien 2016 – Dyslipidämien
Sinning, D., & Landmesser, U. (2016) · Herz · doi:10.1007/s00059-016-4505-6 · Cited by 5
Miopatía asociada al uso de estatinas en la práctica clínica. Resultados del estudio DAMA
Millán, J., Pedro‐Botet, J., Climent, E., Millán, J., & Rius, J. (2016) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2016.07.003 · Cited by 4
Usefulness of compounds with monacolin K in a case of statins intolerance
Parra‐Virto, A., do Rego, A. T., Rodríguez, P. D., Núñez-Cortés, J. M., & Alvarez-Sala, L. A. (2018) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2018.06.003 · Cited by 4
Pavanello, C., Cincotto, G., Mombelli, G. G., Castiglione, S., Santolamazza, C., Calabresi, L., Sirtori, C. R., & Albertí, A. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.09.033 · Cited by 3
Mangone, L. A., Kwon, O. S., Johnson, B. T., Wu, Y., & Pescatello, L. S. (2024) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2024.01.003 · Cited by 5
Self-citationDiévart, F., Bruckert, É., Aboyans, V., Bekka, S., Boccara, F., Munoz, B. B. B., Emmerich, J., Farnier, M., Gallo, A., Lemesle, G., et al. (2024) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2024.02.004 · Cited by 3
Spiegeleer, A. D., Bronselaer, A., Mahieu, I., Vreys, D., Haslbauer, A., Leibfarth, J.-P., Schoote, L. V., Garedow, A. W., Petrovic, M., Wynendaele, E., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01682-x · Cited by 4
The Clinical Presentation of Statin-Associated Muscle Symptoms (SAMS)
Thompson, P. D. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-33304-1_3 · Cited by 3
Self-citationLipid-Targeted Atherosclerotic Risk Reduction in Older Adults: A Review
Hassen, L. J., Scarfone, S. R., & Milks, M. W. (2022) · Geriatrics · doi:10.3390/geriatrics7020038 · Cited by 3
Interactions Between Statins, Exercise, and Health: A Clinical Update
Stierwalt, H. D., McCalley, A. E., McCoin, C. S., & Thyfault, J. P. (2022) · Journal of Clinical Exercise Physiology · doi:10.31189/2165-6193-11.2.54 · Cited by 3
Peyrel, P., Mauriège, P., Frenette, J., Laflamme, N., Greffard, K., Dufresne, S. S., Huth, C., Bergeron, J., & Joanisse, D. R. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.12.002 · Cited by 3
Probing polypharmacy, ageing and sex effects on physical function using different tests
Gemikonakli, G., Mach, J., Tran, T., Wu, H. C., & Hilmer, S. N. (2024) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12978 · Cited by 3
Pharmacological Profile and Mechanisms of Cardiovascular Protective Effects of Statins: An Update
Elhwuegi, A. S., & Elfakhri, M. (2025) · Libyan International Medical University Journal · doi:10.1055/s-0045-1809043 · Cited by 5
Sechs Maßnahmen bei Statin-assoziierten Muskelschmerzen
Klose, G. (2018) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-018-0090-3 · Cited by 3
The problem of safety of lipid-lowering therapy
Zykov, M. V. (2019) · Kardiologiia · doi:10.18087/cardio.2505 · Cited by 3
Orringer, C. E., Blaha, M. J., & Stone, N. J. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.09.052 · Cited by 3
Significance of Statin-Associated Muscle Symptoms and Its Impact on Patients Adherence and Outcomes
Al-Makhamreh, H. K., Toubasi, A. A., Obaid, Y. Y., & Albustanji, F. H. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001386 · Cited by 4
THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW
Napalkov, D. A. (2014) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2014-10-3-334-338 · Cited by 3
Einführung der PCSK9-Inhibitoren
Klose, G. (2016) · Herz · doi:10.1007/s00059-016-4428-2 · Cited by 3
Harder-to-Treat Patients: Recognizing Them and Adapting Treatment Strategies
Miedema, M. D., & Virani, S. S. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.05.027 · Cited by 3
Li, Y., Yang, X., Zou, Y., Li, J., Sun, Q., Jing, X., Yang, M. J., Wang, S., & Dong, B. (2019) · The journal of nutrition health & aging · doi:10.1007/s12603-019-1305-8 · Cited by 3
Yelnik, C., & Bruckert, É. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2020.11.007 · Cited by 4
Mostafa, S. A., Coleman, R. L., Agbaje, O. F., Gray, A. M., Holman, R. R., & Bethel, M. A. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.09.017 · Cited by 3
Grant, J. K., & Orringer, C. E. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.07.007 · Cited by 3
Muhammad, R. N., Aborehab, N. M., Aly, S. H., Nasr, N. N., Hindam, M. O., Mustafa, A. M., Faheem, S. A., Fawzy, M. H., Fetoh, M. E. A., El‐Dessouki, A. M., et al. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-02069-2 · Cited by 5
Peersen, K., Munkhaugen, J., Sverre, E., Kristiansen, O., Fagerland, M. W., Vethe, N. T., Perk, J., Husebye, E., & Dammen, T. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02422-7 · Cited by 3
Yang, N. V., Rogers, S. W., Guerra, R. M., Chao, J. Y., Pagliarini, D. J., Theusch, E., & Krauss, R. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210977 · Cited by 2
Murlasits, Z. (2015) · The Physician and Sportsmedicine · doi:10.1080/00913847.2015.1095618 · Cited by 2
Statin use in carnitine palmitoyltransferase II deficiency
Saeed, A., Hadley, T. D., Jia, X., & Ballantyne, C. M. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.05.001 · Cited by 2
INFLUENCE OF PHYSICAL ACTIVITY PRACTICE IN THE HAND GRIP FORCE-TIME CURVE IN STATINS USERS
Zanini, G. D. S., Bonfim, M. R., Locci, B., Testa, A., & Monteiro, H. L. (2021) · Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida · doi:10.36692/v13n1-28 · Cited by 2
Hypercholesterinämie und kardiovaskuläres Risiko
Sinning, D., & Landmesser, U. (2023) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1932-6448 · Cited by 2
Sychev, D. A., Оstroumova, Т. М., Ostroumova, O. D., Кочетков, А. И., Владимировна, Б. С., & Mironova, E. V. (2023) · Safety and Risk of Pharmacotherapy · doi:10.30895/2312-7821-2023-11-3-252-270 · Cited by 2
Tunçyürekli, M., Tülüce, Y., & Lermioǧlu, F. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03663-x · Cited by 2
Potential effects of probiotics on atherosclerosis
Stuivenberg, G. A., Poon, A., Burton, J. P., & Spence, J. D. (2024) · Microbiome Research Reports · doi:10.20517/mrr.2024.22 · Cited by 2
Benucci, M., Terenzi, R., Gobbi, F. L., Cassarà, E. A. M., Picchioni, T., Russo, E., Lari, B., Manfredi, M., & Infantino, M. G. (2025) · Antibodies · doi:10.3390/antib14030063 · Cited by 2
Genetic Biomarkers for Statin-Induced Myopathy
Prieto-Pena, D., Urriago-Gil, J. D., Ocejo-Vinyals, J. G., García‐Ibarbia, C., Salmón, Z., Martín-Millán, M., Corrales-Selaya, C., Pulito‐Cueto, V., López‐Mejías, R., Blanco, R., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211144 · Cited by 2
StatinWISE sheds new light on statin-related muscle symptoms
Liuzzo, G., & Patrono, C. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab220 · Cited by 3
Pedro‐Botet, J., & Pintó, X. (2015) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2015.10.006 · Cited by 2
Douleurs musculaires et statines, effet pharmaco ou effet nocebo ?
Khouri, C., Lepelley, M., Mallaret, M., Roustit, M., & Cracowski, J. (2017) · Therapies · doi:10.1016/j.therap.2017.12.004 · Cited by 2
Sorrentino, M. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-810422-4.00029-4 · Cited by 2
Mammen, A. L. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.10.004 · Cited by 2
Complications musculaires des statines
Vergès, B. L. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2021.07.007 · Cited by 2
Biomarkers of statin-induced musculoskeletal pain: Vitamin D and beyond
Malaguarnera, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818988-7.00015-7 · Cited by 2
Indicaciones para el uso de los inhibidores de la PCSK9
Rodrigo Alonso, K., & Cuevas, A. M. (2017) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2017.08.020 · Cited by 2
Management of Hyperlipidemia in 2015
Feingold, K. R. (2015) · The Endocrine Society eBooks · doi:10.1210/mtp4.9781936704941.ch24 · Cited by 2
Hubal, M. J., Miles, M. P., Rawson, E. S., Sayers, S. P., Urso, M. L., & Fragala, M. S. (2013) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000000358 · Cited by 2
Wilson, G. N. (2023) · medRxiv · doi:10.1101/2023.03.24.23287706 · Cited by 3
Effects of HMGCR deficiency on skeletal muscle developmentPreprint
Gunasekaran, M., Littel, H. R., Wells, N. M., Turner, J., Campos, G., Venigalla, S., Estrella, E. A., Ghosh, P. S., Daugherty, A. L., Stafki, S. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.06.591934 · Cited by 2
Management of Statin Intolerance
Bartłomiejczyk, M. A., Penson, P. E., & Banach, M. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_12 · Cited by 1
Statins: The Backbone of Treatment of Dyslipidemia
Yadav, S., Mishra, S., & Agarwala, R. (2021) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20210902.13 · Cited by 1
Escher, A. R., Hoffman, J. P., Alfieri, S. E., Bordoni, B., & Evans, R. M. (2022) · Cureus · doi:10.7759/cureus.22777 · Cited by 1
Başaran, Ö. (2020) · Updates in Cardiology · doi:10.5543/ucard.2019.09719 · Cited by 2
Sintomatología muscular asociada a estatinas: ¿mito o realidad?
Blanco, A. M., Gómez-Huelgas, R., & Gómez-Cerezo, J. F. (2022) · Revista Clínica Española · doi:10.1016/j.rce.2022.03.013 · Cited by 2
Efficacy and Safety of Bempedoic Acid in Lipid Disorder Therapy: A Review of Clinical Trials
Dąbrowska, P., Żuber, M., & Dacka, M. (2024) · Prospects in Pharmaceutical Sciences · doi:10.56782/pps.208 · Cited by 1
Bakar, N. S., & Salleh, N. N. H. N. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00896-2 · Cited by 1
Putko, B. N., Milone, M., & Liewluck, T. (2025) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200573 · Cited by 1
2025 Egyptian guidelines for the management of dyslipidemia
Reda, A., Taha, H., Badran, H. M., Khamis, H., Kamal, S., Elserafy, A. S., Dawoud, M. H., Elamragy, A. A., Bendary, A., & Shaker, M. M. (2026) · The Egyptian Heart Journal · doi:10.1186/s43044-026-00716-9 · Cited by 1
Riaz, A. R., Islam, M., & Saeed, H. (2026) · In Silico Pharmacology · doi:10.1007/s40203-026-00560-4 · Cited by 1
Adipose Tissue Aging and Natural Interventions: Potential Roles of Polyphenols and Polysaccharides
Chen, Z.-J., Zhao, Z.-Y., Chen, Y.-Y., Li, Z. Y., & Cheng, Y. (2026) · Nutrients · doi:10.3390/nu18060927 · Cited by 2
Metadata
- Authors
- Parker, B. A., Capizzi, J. A., Grimaldi, A. S., Clarkson, P. M., Cole, S. M., Keadle, J., Chipkin, S., Pescatello, L. S., Simpson, K., White, C. M., & Thompson, P. D.
- Affiliations
- Hartford Hospital (US)
- Venue
- Circulation
- Published
- 2013-01
- Volume
- 127
- Issue
- 1
- Pages
- 96-103
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC4450764
- OpenAlex
- W1982914740
- Cited by
- 500
- References
- 27
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 30 · 2023: 25 · 2022: 43 · 2021: 39 · 2020: 37 · 2019: 39 · 2018: 42 · 2017: 41 · 2016: 57 · 2015: 52 · 2014: 33 · 2013: 17
- FWCI
- 33.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL081893)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- statins, atorvastatin, skeletal muscle function, muscle strength, exercise capacity, creatine kinase, myalgia, statin-induced myopathy, high-intensity statin therapy, healthy volunteers
- MeSH terms
- Atorvastatin, Adult, Creatine Kinase, Double-Blind Method, Exercise Test, Female, Heptanoic Acids, Humans, Male, Middle Aged, Placebos, Pyrroles, Exercise Tolerance, Muscle, Skeletal, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Muscle Strength, Young Adult, Musculoskeletal Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
